DYADIC INTERNATIONAL INC Investment Income, Amortization of Premium
DYADIC INTERNATIONAL INC (DYAI) reported Investment Income, Amortization of Premium of $33.79 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeAmortizationOfPremium · last filed 2023-03-29
- DYADIC INTERNATIONAL INC investment income, amortization of premium for the quarter ending 2022-12-31 was -$3.30K, a 104.38% decline year-over-year.
- DYADIC INTERNATIONAL INC investment income, amortization of premium for the quarter ending 2022-09-30 was $11.88K, a 87.46% decline year-over-year.
- DYADIC INTERNATIONAL INC investment income, amortization of premium for the quarter ending 2022-06-30 was -$13.42M.
- DYADIC INTERNATIONAL INC investment income, amortization of premium for the quarter ending 2022-03-31 was $13.45M, a 78.97% decline year-over-year.
- DYADIC INTERNATIONAL INC investment income, amortization of premium for fiscal 2022 was $33.79K, a 89.75% decline from fiscal 2021.
- DYADIC INTERNATIONAL INC investment income, amortization of premium for fiscal 2021 was $329.61K, a 0.50% decline from fiscal 2020.
- DYADIC INTERNATIONAL INC investment income, amortization of premium for fiscal 2020 was $331.28K, a 67.14% increase from fiscal 2019.
- DYADIC INTERNATIONAL INC investment income, amortization of premium for fiscal 2019 was $198.21K, a 70.71% decline from fiscal 2018.
| Period end | Investment Income, Amortization of Premium 3 month | Investment Income, Amortization of Premium 3 month as first filed | Investment Income, Amortization of Premium 6 month | Investment Income, Amortization of Premium 9 month | Investment Income, Amortization of Premium 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | -$3.30K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $8.57K derived: sum of 2 quarters · filed 2023-03-29 | -$13.41M derived: sum of 3 quarters · filed 2023-03-29 | $33.79K 10-K · filed 2023-03-29 | |
| 2022-09-30 | $11.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$13.41M derived: sum of 2 quarters · filed 2022-11-10 | $37.09K 10-Q · filed 2022-11-10 | $112.51K derived: sum of 4 quarters · filed 2023-03-29 | |
| 2022-06-30 | -$13.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $25.22K 10-Q · filed 2022-08-10 | $100.64K derived: sum of 3 quarters · filed 2023-03-29 | $195.35K derived: sum of 4 quarters · filed 2023-03-29 | |
| 2022-03-31 | $13.45M 10-Q · filed 2022-05-12 | $13.52M derived: sum of 2 quarters · filed 2023-03-29 | $13.62M derived: sum of 3 quarters · filed 2023-03-29 | -$50.18M derived: sum of 4 quarters · filed 2023-03-29 | |
| 2021-12-31 | $75.42K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $170.13K derived: sum of 2 quarters · filed 2023-03-29 | -$63.62M derived: sum of 3 quarters · filed 2023-03-29 | $329.61K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $94.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$63.70M derived: sum of 2 quarters · filed 2022-11-10 | $254.19K 10-Q · filed 2022-11-10 | $303.35K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$63.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $159.48K 10-Q · filed 2022-08-10 | $208.63K derived: sum of 3 quarters · filed 2022-08-10 | $260.84K derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $63.95M 10-Q · filed 2022-05-12 | $63.95K 10-Q · filed 2021-05-13 | $64.00M derived: sum of 2 quarters · filed 2022-05-12 | $64.05M derived: sum of 3 quarters · filed 2022-05-12 | $64.18M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $49.15K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $101.36K derived: sum of 2 quarters · filed 2022-03-29 | $224.02K derived: sum of 3 quarters · filed 2022-03-29 | $331.28K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $52.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $174.87K derived: sum of 2 quarters · filed 2021-11-10 | $282.12K 10-Q · filed 2021-11-10 | $338.97K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $122.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $229.92K 10-Q · filed 2021-08-12 | $286.76K derived: sum of 3 quarters · filed 2021-08-12 | $337.34K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $107.26K 10-Q · filed 2021-05-13 | $164.10K derived: sum of 2 quarters · filed 2021-05-13 | $214.68K derived: sum of 3 quarters · filed 2021-05-13 | $273.26K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $56.85K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $107.42K derived: sum of 2 quarters · filed 2021-03-30 | $166.01K derived: sum of 3 quarters · filed 2021-03-30 | $198.21K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $50.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $109.16K derived: sum of 2 quarters · filed 2020-11-12 | $141.36K 10-Q · filed 2020-11-12 | $219.54K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $58.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $90.78K 10-Q · filed 2020-08-13 | $168.97K derived: sum of 3 quarters · filed 2020-08-13 | $275.03K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $32.20K 10-Q · filed 2020-05-14 | $110.38K derived: sum of 2 quarters · filed 2020-05-14 | $216.45K derived: sum of 3 quarters · filed 2020-05-14 | $424.12K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $78.18K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $184.25K derived: sum of 2 quarters · filed 2020-03-30 | $391.91K derived: sum of 3 quarters · filed 2020-03-30 | $676.64K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $106.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $313.73K derived: sum of 2 quarters · filed 2019-11-13 | $598.46K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $207.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $492.40K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $284.73K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | $1.11M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |